The Evolving Paradigm of Liquid Biopsy in Precision Medicine Driven Drug Development- Opportunities and Challenges of using Minimal Residual Disease (MRD) in Solid Cancers
Time: 10:00 am
day: Day One
This event ran on
November 16-17, 2022
